QURE
Uniqure NV
NASDAQ: QURE · HEALTHCARE · BIOTECHNOLOGY
$44.51
+0.09% today
Updated 2026-09-11
Market cap
$3.17B
P/E ratio
—
P/S ratio
169.70x
EPS (TTM)
$-4.06
Dividend yield
—
52W range
$9 – $72
Volume
1.3M
Uniqure NV (QURE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$44.51
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.5B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -15.57% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.